Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TERT promoter mutations and gene amplification in endometrial cancer.

Gynecologic oncology - 1 Dec 2023

Praiss Aaron M, Marra Antonio, Zhou Qin, Rios-Doria Eric, Momeni-Boroujeni Amir, Iasonos Alexia, Selenica Pier, Brown David N, Aghajanian Carol, Abu-Rustum Nadeem R, Ellenson Lora H, Weigelt Britta

Abstract excerpt

OBJECTIVE: To assess the clinicopathologic, molecular profiles, and survival outcomes of patients with endometrial carcinomas (ECs) harboring telomerase reverse transcriptase (TERT) hotspot mutations or gene amplification. METHODS: ECs harboring somatic TERT promoter hotspot mutations or gene amplification (TERT-altered) were identified from 1944 ECs that underwent clinical tumor-normal sequencing from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial Neoplasms
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Promoter Regions, Genetic

Share to Telomerase

Source

Open in PubMed Open full text

Identifiers

PMID: 37890416
DOI: 10.1016/j.ygyno.2023.10.007
PMCID: PMC10841990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TERT promoter mutations and gene amplification in endometrial cancer.PMID 37890416Read ↗

The mutational landscape of endometrial cancer.Semantic proximity Read ↗

Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer.Semantic proximity Read ↗

Whole-genome sequencing-based characterization of endometrial serous carcinoma.Semantic proximity Read ↗

Molecular heterogeneity of endometrial cancer in the real-world: Biomarker patterns by tumor stage, histology, and molecular subtype.Semantic proximity Read ↗

Impact of TP53 somatic mutations on prognosis in endometrial cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.Semantic proximity Read ↗

Molecular subtypes and genomic landscape of undifferentiated and dedifferentiated endometrial cancer.Semantic proximity Read ↗

Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer.Semantic proximity Read ↗

Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.Semantic proximity Read ↗

TERT promoter mutations and monoallelic activation of TERT in cancerSemantic proximity Read ↗

Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma.Semantic proximity Read ↗

Mutation and methylation profiles of ectopic and eutopic endometrial tissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.